BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC 35th Anniversary Annual Meeting

9. November 2020 INDIZES WEUR

BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC 35th Anniversary Annual Meeting …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...